Synapse - September 2019
von mehreren Autoren
Webinar: Recent legislative developments affecting biologics and biosimilars
von Matthew Royle, Ph.D. und Evelyne Friedel
The Court of Justice on skinny labels
No compulsory licence for Sanofi's Praluent in Germany
SPC manufacturing waiver for export and stockpiling comes into force
Recent legislative developments affecting biologics and biosimilars
von mehreren Autoren
Brexit update – 'Grandfathering' marketing authorisations
von Dr Paul England
Essentially biological processes and their products – what is patentable?
von Dr Paul England
Biosimilars webinar series – Recent developments in biosimilars settlements, market landscape and antitrust scrutiny
von mehreren Autoren
Plausibility of second medical use patents: pregabalin in the Supreme Court
von Matthew Royle, Ph.D. und Dr Paul England
The grant of an SPC for a new therapeutic application